3 Reasons to Buy 2014's Smartest Company

Gene sequencing stock Illumina has exploded onto the scene with huge gains for investors, but could the best be yet to come for this exciting company?

Mar 6, 2014 at 6:30PM

Looking for one of the new year's fastest-rising stocks? Look no further than Illumina (NASDAQ:ILMN), the gene-sequencing giant that's taken the market by storm, gaining more than 250% over the past two years. However, that rapid climb has given way to caution: Some now worry about the stock's sky-high valuation and whether it's worth a buy or not.

For the long-term investor, however, Illumina is full of potential in the long run. The company's the dominant early leader in a growing genetic sequencing market that some analysts predict could reach $20 billion annually in the near future. It's hard to find a more innovative company on the markets, as well: MIT Technology Review recently ranked Illumina as its number-one firm on its "50 Smartest Companies" list for 2014, citing the firm's dominant 70% market share in the industry and its development of groundbreaking technologies, such as the $1,000 human genome. Illumina's dominance in the early days of the gene sequencing market have the company poised to ride its innovation and brains to years of success.

Will that translate to the firm's high-flying stock over the the coming years, however? Find out in the video below, as Motley Fool contributor Dan Carroll tells you three reasons why Illumina is a great stock for any investor thinking in the long run -- and why this health care stock's run-up might be only the beginning.

Looking for the next great stock opportunity?
As Illumina investors have found out, opportunities to get wealthy from a single investment don't come around often, but they do exist, and our chief technology officer believes he's found one. In this free report, Jeremy Phillips shares the single company that he believes could transform not only your portfolio, but your entire life. To learn the identity of this stock for free and see why Jeremy is putting more than $100,000 of his own money into it, all you have to do is click here now.

Dan Carroll has no position in any stocks mentioned. The Motley Fool recommends Illumina and Thermo Fisher Scientific. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Money to your ears - A great FREE investing resource for you

The best way to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as “binge-worthy finance.”

Feb 1, 2016 at 5:03PM

Whether we're in the midst of earnings season or riding out the market's lulls, you want to know the best strategies for your money.

And you'll want to go beyond the hype of screaming TV personalities, fear-mongering ads, and "analysis" from people who might have your email address ... but no track record of success.

In short, you want a voice of reason you can count on.

A 2015 Business Insider article titled, "11 websites to bookmark if you want to get rich," rated The Motley Fool as the #1 place online to get smarter about investing.

And one of the easiest, most enjoyable, most valuable ways to get your regular dose of market and money insights is our suite of free podcasts ... what we like to think of as "binge-worthy finance."

Whether you make it part of your daily commute or you save up and listen to a handful of episodes for your 50-mile bike rides or long soaks in a bubble bath (or both!), the podcasts make sense of your money.

And unlike so many who want to make the subjects of personal finance and investing complicated and scary, our podcasts are clear, insightful, and (yes, it's true) fun.

Our free suite of podcasts

Motley Fool Money features a team of our analysts discussing the week's top business and investing stories, interviews, and an inside look at the stocks on our radar. The show is also heard weekly on dozens of radio stations across the country.

The hosts of Motley Fool Answers challenge the conventional wisdom on life's biggest financial issues to reveal what you really need to know to make smart money moves.

David Gardner, co-founder of The Motley Fool, is among the most respected and trusted sources on investing. And he's the host of Rule Breaker Investing, in which he shares his insights into today's most innovative and disruptive companies ... and how to profit from them.

Market Foolery is our daily look at stocks in the news, as well as the top business and investing stories.

And Industry Focus offers a deeper dive into a specific industry and the stories making headlines. Healthcare, technology, energy, consumer goods, and other industries take turns in the spotlight.

They're all informative, entertaining, and eminently listenable. Rule Breaker Investing and Answers are timeless, so it's worth going back to and listening from the very start; the other three are focused more on today's events, so listen to the most recent first.

All are available for free at www.fool.com/podcasts.

If you're looking for a friendly voice ... with great advice on how to make the most of your money ... from a business with a lengthy track record of success ... in clear, compelling language ... I encourage you to give a listen to our free podcasts.

Head to www.fool.com/podcasts, give them a spin, and you can subscribe there (at iTunes, Stitcher, or our other partners) if you want to receive them regularly.

It's money to your ears.

 


Compare Brokers